Newsroom | 4761 results

BOSTON & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Leveragen, a Boston-based biotechnology company pioneering next-generation in vivo antibody discovery platforms, announced today a strategic collaboration with Propeller Bio, a newly launched biotechnology company focused on antibody and protein-based therapeutics. As part of the partnership, Propeller Bio will support the continued development of Leveragen’s antibody discovery platforms through a strategic investment. In turn, Propeller wi...

WASHINGTON--(BUSINESS WIRE)--The American College of Diabetology (ACD) announced that Diabetology has received formal recognition through the assignment of a unique taxonomy classification. This marks a historic milestone for the field, affirming the specialized expertise of physicians who focus exclusively or primarily on diabetes care. “This recognition is about formally naming a field that already exists in practice — one where clinicians devote their careers to comprehensive, patient-center...

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW (“Know Labs” or the “Company”), a technology innovator specializing in non-invasive health monitoring solutions, today announced that it has adjourned its Special Meeting of Stockholders (the “Special Meeting”) scheduled for July 24, 2025 in order to provide stockholders additional time to vote on all proposals described in the Company’s definitive proxy statement for the Special Meeting, filed with the Securities and Exchange Commis...

BASEL, Switzerland--(BUSINESS WIRE)--Ascensia Diabetes Care, a global diabetes care company, maker of the CONTOUR® Blood Glucose Monitoring (BGM) System portfolio and exclusive distributor of Eversense® Continuous Glucose Monitoring (CGM) Systems, has launched its fourth annual global art competition in support of World Diabetes Day 2025. This year, the competition is themed around Diabetes and Anxiety, shining a spotlight on the mental health impact of diabetes and capturing the unfiltered rea...

SAN FRANCISCO--(BUSINESS WIRE)--Vida Health today announced the appointment of Jason Macaleer as Chief Strategy Officer and Mike Rolla as Chief Growth Officer....

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today issued a statement to address questions about the status of its ongoing Exclusive License and Collaboration Agreement with Sarepta Therapeutics. Arrowhead continues to conduct clinical and non-clinical studies as stipulated in the agreement, and it expects Sarepta to continue to meet its required financial obligations. Sarepta has provided no indication of any intention to fail to fulfill any of its obligati...

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW) (“Know Labs” or the “Company”), a technology innovator specializing in non-invasive health monitoring solutions, today issued a reminder to its stockholders to vote ahead of the Special Meeting of Stockholders (the “Special Meeting”) to be held virtually on Thursday, July 24, 2025 at 1:30 p.m. pacific time. The methods for voting and submitting proxies are described in the previously distributed proxy materials for the Special Meeti...

COLUMBIA, Md.--(BUSINESS WIRE)--Welldoc®, a leading digital health company pioneering AI-driven cardiometabolic care, and Databricks, the Data and AI company, today announced the expansion of their strategic partnership. Building on a successful collaboration established in 2023, Welldoc is now formally recognized as a participant in the Built on Databricks program. This strategic collaboration leverages Databricks' powerful Data Intelligence Platform to enhance Welldoc's advanced analytics and...

DUBLIN--(BUSINESS WIRE)--The "Europe Glucagon-like Peptide-1 (GLP-1) Agonists Market Report and Forecast 2025-2034" has been added to ResearchAndMarkets.com's offering. The Europe glucagon-like peptide-1 (GLP-1) agonists market is projected to witness significant growth, fueled primarily by an increased prevalence of type 2 diabetes and obesity. Originally valued at USD 7.09 billion in 2024, the market is estimated to expand at a compound annual growth rate (CAGR) of 17.30%, expecting a valuati...

DUBLIN--(BUSINESS WIRE)--The "GLP-1 Agonists Drug Pipeline Analysis Report 2025" drug pipelines has been added to ResearchAndMarkets.com's offering. The GLP-1 Agonists Drug Pipeline Insight Report gives comprehensive insights into GLP-1 agonists therapeutics currently undergoing clinical trials. It covers various aspects related to the details of each of these drugs under development for GLP-1 agonists. The GLP-1 agonists report assessment includes the analysis of over 100 pipeline drugs and 50...